Second Targeted Therapeutic Approved for Use Based on Tumor Biomarker, Not Tumor Origin
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
Tag: tissue-agnostic therapies
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
Cancer treatments have been, and continue to be in most cases, based on the organ site where the tumor...